Journal of the Society for Cardiovascular Angiography & Interventions最新文献

{"title":"Tricuspid Valve Dysfunction: Role of Exercise Invasive Hemodynamic Assessment","authors":"Ashish H. Shah MD , Triston Eastman MD , Robin A. Ducas MD , James W. Tam MD","doi":"10.1016/j.jscai.2025.103613","DOIUrl":"10.1016/j.jscai.2025.103613","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 6","pages":"Article 103613"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of Tricuspid Transcatheter Edge-to-Edge Valve Repair in End-Stage Renal Disease","authors":"Lamiya Rodriguez MD, Keniel Pierre MD, JoAnn Lindenfeld MD, Rebecca Hung MD, Tarek Absi MD, Angela Lowenstern MD, Brian Lindman MD, Colin Barker MD, Kashish Goel MD","doi":"10.1016/j.jscai.2025.102643","DOIUrl":"10.1016/j.jscai.2025.102643","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 6","pages":"Article 102643"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Inpatient Outcomes of Tricuspid Transcatheter Edge-to-Edge Repair in the United States Based on Sex","authors":"Amanda Nguyen MD ,&nbsp;Muhammad Zia Khan MD, MS ,&nbsp;Waleed Alruwaili MD ,&nbsp;Sameh Nassar MD ,&nbsp;Zahoor Khan MD ,&nbsp;Price Thomas DO ,&nbsp;Sherif Elhosseiny MD ,&nbsp;Juan Siordia MD ,&nbsp;Richard Kovach MD ,&nbsp;Muhammad Raza MD","doi":"10.1016/j.jscai.2025.102644","DOIUrl":"10.1016/j.jscai.2025.102644","url":null,"abstract":"<div><h3>Background</h3><div>Tricuspid transcatheter edge-to-edge repair (T-TEER) has emerged as an effective and safe option for the repair of tricuspid regurgitation in select patients. Prior studies on invasive and percutaneous cardiac interventions have shown differential outcomes based on sex, but specific studies investigating T-TEER outcomes on a national level are limited.</div></div><div><h3>Methods</h3><div>The National Inpatient Sample and International Classification of Diseases, Tenth Revision codes were used to identify patients who underwent T-TEER in the US from 2018 to 2021. The study group was then stratified based on sex. Study end points assessed included inpatient complications, outcomes, and resource utilization after T-TEER. A multivariable logistic regression model was used to assess the independent association of sex with study outcomes.</div></div><div><h3>Results</h3><div>A total of 1960 T-TEER procedures were identified, of which 1210 occurred in female patients (61.7%). Female patients were older and generally had a lower prevalence of important comorbidities than male patients. In unadjusted analysis, female sex was associated with lower prevalence of major, overall, and cardiovascular complications, inpatient mortality, and length and cost of stay. After multivariable adjustment, female sex was associated with lower inpatient mortality (adjusted odds ratio [aOR], 0.43; 95% CI, 0.22-0.82), lower major complications, (aOR, 0.69; 95% CI, 0.49-0.98), and lower cost of stay (aOR, 0.67; 95% CI, 0.55-0.82).</div></div><div><h3>Conclusions</h3><div>Female sex was associated with similar or better inpatient outcomes and mortality after T-TEER when compared with male sex. Further investigation to understand the etiology behind these important differences is encouraged to promote improved cardiovascular care and outcomes in patients regardless of sex.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 6","pages":"Article 102644"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cost-Utility Analysis of Endovascular Ultrasound Renal Denervation to Treat Resistant Hypertension in the United States","authors":"Rod S. Taylor MSc, PhD ,&nbsp;Kieran Murphy MPH ,&nbsp;Noam Kirson PhD ,&nbsp;Jack Pfefferkorn BA ,&nbsp;Ajay J. Kirtane MD, SM ,&nbsp;Michel Azizi MD, PhD ,&nbsp;Peter Neumann ScD","doi":"10.1016/j.jscai.2025.103601","DOIUrl":"10.1016/j.jscai.2025.103601","url":null,"abstract":"<div><h3>Background</h3><div>This study evaluated the cost utility of ultrasound renal denervation (uRDN) for resistant hypertension in the United States.</div></div><div><h3>Methods</h3><div>A previously published Markov model was adapted to compare total costs and quality-adjusted life years (QALY) between uRDN plus standard of care (SoC) vs SoC alone over a lifetime horizon from a US health care system perspective. Patient characteristics and clinical inputs were drawn from the RADIANCE-HTN TRIO trial, and the incidence of key cardiovascular events was estimated using published risk equations. Utility values and US health care cost inputs were based on a targeted literature review. Incremental cost-effectiveness ratio was evaluated against standard cost-effectiveness thresholds ranging from $50,000 to $100,000 per QALY. Scenario, deterministic, and probabilistic sensitivity analyses were used to assess the robustness of findings. All costs and QALY were discounted at 3% per year.</div></div><div><h3>Results</h3><div>In the base case analysis, an 8.5 mm Hg reduction in systolic blood pressure with uRDN compared with SoC alone resulted in lower relative risks of cardiovascular events and additional life years (15.00 vs 14.29) and QALY (12.01 vs 11.42). Using a procedure cost of $23,000, total lifetime costs were higher with the uRDN procedure (uRDN plus SoC: $110,476 vs SoC alone: $102,875), resulting in an incremental cost-effectiveness ratio of $12,900 per QALY. Sensitivity and scenario analyses demonstrate that the findings were robust to changes in key model inputs including a systolic blood pressure reduction with uRDN from –5.0 to –9.6 mm Hg.</div></div><div><h3>Conclusions</h3><div>Evaluated against conventional cost-effectiveness thresholds in the US, the addition of uRDN is estimated to offer a cost-effective approach alongside lifestyle modification and antihypertensive medications for patients with resistant hypertension.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 6","pages":"Article 103601"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is Percutaneous Mechanical Atherothrombectomy a Durable, Cost-Effective Solution for the Treatment of Femoropopliteal In-Stent Reocclusion?","authors":"Thomas Zeller MD","doi":"10.1016/j.jscai.2025.103669","DOIUrl":"10.1016/j.jscai.2025.103669","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 6","pages":"Article 103669"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Innovative Use of Coronary GuideLiner to Facilitate Patent Ductus Arteriosus Stent Reintervention","authors":"Bayan Issa MD ,&nbsp;Marjan Hesari MD ,&nbsp;Brent M. Gordon MD ,&nbsp;Justin R. Ryan MD ,&nbsp;Anna Hedberg MD ,&nbsp;Clinton Fulk BSRS, RT(R)(ARRT) ,&nbsp;Ryan Reeves MD ,&nbsp;Howaida El-Said MD, PhD","doi":"10.1016/j.jscai.2025.103576","DOIUrl":"10.1016/j.jscai.2025.103576","url":null,"abstract":"<div><div>This is the first report using a coronary GuideLiner (Teleflex) to overcome the challenge of patent ductus arteriosus (PDA) stent crossing and restenting. We present 2 patients, a 3-month-old and a 15-month-old, with complex cyanotic heart disease and ductal-dependent pulmonary blood flow who previously underwent PDA stenting and required reintervention on the PDA stent. Historically, patients who require reintervention for PDA stenting have been challenging, especially when restenting is needed. The use of the GuideLiner was a game-changer in these 2 cases.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 6","pages":"Article 103576"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women","authors":"Suzanne J. Baron MD, MSc, FSCAI ,&nbsp;Josephine C. Chou MD, MS ,&nbsp;Tayyab Shah MD ,&nbsp;Amanda R. Vest MBBS, MPH ,&nbsp;J. Dawn Abbott MD, FSCAI ,&nbsp;Mirvat Alasnag MD ,&nbsp;Cristina Aurigemma MD ,&nbsp;Emanuele Barbato MD ,&nbsp;Lavanya Bellumkonda MD ,&nbsp;Anna E. Bortnick MD, PhD, MS, FSCAI ,&nbsp;Alaide Chieffo MD ,&nbsp;Robert-Jan van Geuns MD ,&nbsp;Cindy L. Grines MD, MSCAI ,&nbsp;Sigrun Halvorsen MD ,&nbsp;Christian Hassager MD ,&nbsp;Navin K. Kapur MD, FSCAI ,&nbsp;Srihari S. Naidu MD, FSCAI ,&nbsp;Vivian G. Ng MD, FSCAI ,&nbsp;Jacqueline Saw MD, FSCAI ,&nbsp;Alexandra J. Lansky MD, MSCAI","doi":"10.1016/j.jscai.2024.102150","DOIUrl":"10.1016/j.jscai.2024.102150","url":null,"abstract":"<div><div>Cardiovascular disease is the leading cause of death for women worldwide, with mortality rates due to cardiogenic shock (CS) remaining exceedingly high. Sex-based disparities in the timely delivery of optimal CS treatment contribute to poor outcomes; addressing these disparities is a major priority to improve women’s cardiovascular health. This consensus statement provides a comprehensive summary of the current state of treatment of CS in women across the spectrum of cardiovascular disease states and identifies important gaps in evidence. As sex-based data are limited in contemporary literature, clinicians may use this document as a resource to guide practice. Further investigations are necessary to inform best practices for the diagnosis and treatment of women with CS.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 6","pages":"Article 102150"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mechanical Circulatory Support Reduces Directly Recorded Cardiac Sympathetic Nerve Activity in Ovine Acute Myocardial Infarction","authors":"Tania Warnakulasuriya MBBS, MPhil ,&nbsp;Bindu George MSc ,&nbsp;Nigel Lever MBChB ,&nbsp;Rohit Ramchandra MSc, PhD","doi":"10.1016/j.jscai.2025.102642","DOIUrl":"10.1016/j.jscai.2025.102642","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 6","pages":"Article 102642"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiation Safety Renaissance: Will State Regulations Help or Hinder an Emergence From the Dark Ages?","authors":"Ryan D. Madder MD","doi":"10.1016/j.jscai.2025.103612","DOIUrl":"10.1016/j.jscai.2025.103612","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 6","pages":"Article 103612"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cover","authors":"","doi":"10.1016/S2772-9303(25)01221-9","DOIUrl":"10.1016/S2772-9303(25)01221-9","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 6","pages":"Article 103779"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}